APA (7th ed.) Citation

Zhang, Z., Li, L., Ge, Y., Chen, A., Diao, S., Yang, Y., . . . Li, R. (2025). Verteporfin‐Mediated In Situ Nanovaccine Based on Local Conventional‐Dose Hypofractionated Radiotherapy Enhances Antitumor and Immunomodulatory Effect. Advanced Science, 12(20), 1. https://doi.org/10.1002/advs.202413387

Chicago Style (17th ed.) Citation

Zhang, Zhifan, et al. "Verteporfin‐Mediated In Situ Nanovaccine Based on Local Conventional‐Dose Hypofractionated Radiotherapy Enhances Antitumor and Immunomodulatory Effect." Advanced Science 12, no. 20 (2025): 1. https://doi.org/10.1002/advs.202413387.

MLA (9th ed.) Citation

Zhang, Zhifan, et al. "Verteporfin‐Mediated In Situ Nanovaccine Based on Local Conventional‐Dose Hypofractionated Radiotherapy Enhances Antitumor and Immunomodulatory Effect." Advanced Science, vol. 12, no. 20, 2025, p. 1, https://doi.org/10.1002/advs.202413387.